Abstract
Brain arteriovenous malformations (AVMs) cause intracranial hemorrhage (ICH), especially in young adults. Molecular characterization of lesional tissue provides evidence for involvement of both angiogenic and inflammatory pathways, but the pathogenesis remains obscure and medical therapy is lacking. Abnormal expression patterns have been observed for proteins related to angiogenesis (e.g., vascular endothelial growth factor, angiopoietin-2, matrix metalloproteinase-9), and inflammation (e.g., interleukin-6 [IL-6] and myeloperoxidase). Macrophage and neutrophil invasion have also been observed in the absence of prior ICH. Candidate gene association studies have identified a number of germline variants associated with clinical ICH course and AVM susceptibility. A single nucleotide polymorphism (SNP) in activin receptor-like kinase-1 (ALK-1) is associated with AVM susceptibility, and SNPs in IL-6, tumor necrosis factor-a (TNF-a), and apolipoprotein-E (APOE) are associated with AVM rupture. These observations suggest that even without a complete understanding of the determinants of AVM development, the recent discoveries of downstream derangements in vascular function and integrity may offer potential targets for therapy development. Further, biomarkers can now be established for assessing ICH risk. These data will generate hypotheses that can be tested mechanistically in model systems, including surrogate phenotypes, such as vascular dys-plasia and/or models recapitulating the clinical syndrome of recurrent spontaneous ICH.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
References
Achrol AS, Pawlikowska L, McCulloch CE, Poon KY, Ha C, Zaroff JG, Johnston SC, Lee C, Lawton MT, Sidney S, Marchuk DA, Kwok PY, Young WL (2006) Tumor necrosis factor-alpha-238G > A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke 37: 231–234
Achrol AS, Kim H, Pawlikowska L, Trudy Poon KY, McCulloch CE, Ko NU, Johnston SC, McDermott MW, Zaroff JG, Lawton MT, Kwok PY, Young WL (2007) Association of tumor necrosis factor-alpha-238G>A and apolipoprotein E2 polymorphisms with in-tracranial hemorrhage after brain arteriovenous malformation treatment. Neurosurgery 61: 731–740
Al-Shahi R, Fang JS, Lewis SC, Warlow CP (2002) Prevalence of adults with brain arteriovenous malformations: a community based study in Scotland using capture-recapture analysis. J Neurol Neurosurg Psychiatry 73: 547–551
Arteriovenous Malformation Study Group (1999) Arteriovenous malformations of the brain in adults. N Engl J Med 340:1812–1818
Bayrak-Toydemir P, McDonald J, Akarsu N, Toydemir RM, Calderon F, Tuncali T, Tang W, Miller F, Mao R (2006) A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A 140: 2155–2162
Bayrak-Toydemir P, McDonald J, Markewitz B, Lewin S, Miller F, Chou LS, Gedge F, Tang W, Coon H, Mao R (2006) Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet A 140: 463–470
Berman MF, Sciacca RR, Pile-Spellman J, Stapf C, Connolly ES Jr, Mohr JP, Young WL (2000) The epidemiology of brain arteriovenous malformations. Neurosurgery 47: 389–397
Brouillard P, Vikkula M (2007) Genetic causes of vascular malformations. Hum Mol Genet 16(2): R140–R149
Calvert JT, Riney TJ, Kontos CD, Cha EH, Prieto VG, Shea CR, Berg JN, Nevin NC, Simpson SA, Pasyk KA, Speer MC, Peters KG, Marchuk DA (1999) Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet 8: 1279–1289
Cambier S, Gline S, Mu D, Collins R, Araya J, Dolganov G, Einheber S, Boudreau N, Nishimura SL (2005) Integrin alpha(v)-beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: an angiogenic control switch. Am J Pathol 166: 1883–1894
Carter N, Williamson L, Kennedy LG, Brown MA, Wordsworth BP (2000) Susceptibility to ankylosing spondylitis. Rheumatology (Oxford) 39: 445
Chen Y, Xu B, Arderiu G, Hashimoto T, Young WL, Boudreau N, Yang GY (2004) Retroviral delivery of homeobox D3 gene induces cerebral angiogenesis in mice. J Cereb Blood Flow Metab 24: 1280–1287
Chen Y, Fan Y, Poon KY, Achrol AS, Lawton MT, Zhu Y, McCulloch CE, Hashimoto T, Lee C, Barbaro NM, Bollen AW, Yang GY, Young WL (2006) MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. Front Biosci 11: 3121–3128
Chen Y, Pawlikowska L, Yao JS, Shen F, Zhai W, Achrol AS, Lawton MT, Kwok PY, Yang GY, Young WL (2006) Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol 59: 72–80
Chen Y, Zhu W, Bollen AW, Lawton MT, Barbaro NM, Dowd CF, Hashimoto T, Yang GY, Young WL (2008) Evidence for inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery (in press)
Cole SG, Begbie ME, Wallace GM, Shovlin CL (2005) A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 42: 577–582
David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) endothelial cells. Blood 109: 1953–1961
David L, Mallet C, Vailhé B, Lamouille S, Feige JJ, Bailly S (2007) Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: potential roles for JNK and ERK. J Cell Physiol 213: 484–489
Du R, Hashimoto T, Tihan T, Young WL, Perry V, Lawton MT (2007) Growth and regression of arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia. Case report. J Neurosurg 106: 470–477
Duong DH, Young WL, Vang MC, Sciacca RR, Mast H, Koennecke HC, Hartmann A, Joshi S, Mohr JP, Pile-Spellman J (1998) Feeding artery pressure and venous drainage pattern are primary determinants of hemorrhage from cerebral arteriovenous malformations. Stroke 29: 1167–1176
Gallione CJ, Richards JA, Letteboer TG, Rushlow D, Prigoda NL, Leedom TP, Ganguly A, Castells A, Ploos van Amstel JK, Westermann CJ, Pyeritz RE, Marchuk DA (2006) SMAD4 mutations found in unselected HHT patients. J Med Genet 43: 793–797
Happle R (1992) Paradominant inheritance: a possible explanation for Becker’s pigmented hairy nevus. Eur J Dermatol 2: 39–40
Happle R (1993) Klippel-Trenaunay syndrome: is it a paradominant trait? Br J Dermatol 128: 465–466
Hashimoto T, Lam T, Boudreau NJ, Bollen AW, Lawton MT, Young WL (2001) Abnormal balance in the angiopoietin-tie2 system in human brain arteriovenous malformations. Circ Res 89: 111–113
Hashimoto T, Mesa-Tejada R, Quick CM, Bollen AW, Joshi S, Pile-Spellman J, Lawton MT, Young WL (2001) Evidence of increased endothelial cell turnover in brain arteriovenous malformations. Neurosurgery 49: 124–132
Hashimoto T, Wen G, Lawton MT, Boudreau NJ, Bollen AW, Yang GY, Barbaro NM, Higashida RT, Dowd CF, Halbach VV, Young WL (2003) Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke 34: 925–931
Hashimoto T, Lawton MT, Wen G, Yang GY, Chaly T Jr, Stewart CL, Dressman HK, Barbaro NM, Marchuk DA, Young WL (2004) Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery 54: 410–425
Hysi PG, Kim H, Pawlikowska L, McCulloch CE, Zaroff JG, Marchuk DA, Lawton MT, Kwok PY, Young WL (2007) Association of interleukin-1 beta (ILβ) gene and risk of intracranial hemorrhage in brain arteriovenous malformation patients (Abstract #2538). 57th Annual Meeting of the American Society of Human Genetics, San Diego, CA
Hysi PG, Kim H, Pawlikowska L, McCulloch CE, Zaroff JG, Sidney S, Burchard EG, Marchuk DA, Lawton MT, Kwok PY, Young WL (2007) Association of interleukin-1 beta (IL1B) gene and brain arteriovenous malformation in Caucasians (abstract). Stroke 38: 456
Inoue S, Liu W, Inoue K, Mineharu Y, Takenaka K, Yamakawa H, Abe M, Jafar JJ, Herzig R, Koizumi A (2007) Combination of linkage and association studies for brain arteriovenous malformation. Stroke 38: 1368–1370
Kim H, Sidney S, McCulloch CE, Poon KY, Singh V, Johnston SC, Ko NU, Achrol AS, Lawton MT, Higashida RT, Young WL (2007) Racial/ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke 38: 2430–2437
Lamouille S, Mallet C, Feige JJ, Bailly S (2002) Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100: 4495–4501
Langer DJ, Lasner TM, Hurst RW, Flamm ES, Zager EL, King JT Jr (1998) Hypertension, small size, and deep venous drainage are associated with risk of hemorrhagic presentation of cerebral arteriovenous malformations. Neurosurgery 42: 481–489
Lawton MT, Jacobowitz R, Spetzler RF (1997) Redefined role of angiogenesis in the pathogenesis of dural arteriovenous malformations. J Neurosurg 87: 267–274
Lee CZ, Xue Z, Zhu Y, Yang GY, Young WL (2007) Matrix me-talloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage. Stroke 38: 2563–2568
Letteboer TG, Mager JJ, Snijder RJ, Koeleman BP, Lindhout D, Ploos van Amstel JK, Westermann CJ (2006) Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet 43: 371–377
Maher CO, Piepgras DG, Brown RD Jr, Friedman JA, Pollock BE (2001) Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 32: 877–882
Marchuk DA, Srinivasan S, Squire TL, Zawistowski JS (2003) Vascular morphogenesis: tales of two syndromes. Hum Mol Genet 12: R97–R112
Mast H, Young WL, Koennecke HC, Sciacca RR, Osipov A, Pile-Spellman J, Hacein-Bey L, Duong H, Stein BM, Mohr JP (1997) Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet 350: 1065–1068
Matsubara S, Manzia JL, ter Brugge K, Willinsky RA, Montanera W, Faughnan ME (2000) Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. Am J Neuroradiol 21: 1016–1020
Meschia JF, Brown RD Jr, Brott TG, Chukwudelunzu FE, Hardy J, Rich SS (2002) The Siblings With Ischemic Stroke Study (SWISS) protocol. BMC Med Genet 3: 1
Park SO, Lee YJ, Seki T, Hong KH, Fliess N, Jiang Z, Park A, Wu X, Kaartinen V, Roman BL, Oh SP (2008) ALK5-and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood 111: 633–642
Pawlikowska L, Tran MN, Achrol AS, McCulloch CE, Ha C, Lind DL, Hashimoto T, Zaroff J, Lawton MT, Marchuk DA, Kwok PY, Young WL (2004) Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke 35: 2294–2300
Pawlikowska L, Tran MN, Achrol AS, Ha C, Burchard E, Choudhry S, Zaroff J, Lawton MT, Castro R, McCulloch CE, Marchuk D, Kwok PY, Young WL (2005) Polymorphisms in transforming growth factor-beta-related genes ALK1 and ENG are associated with sporadic brain arteriovenous malformations. Stroke 36: 2278–2280
Pawlikowska L, Poon KY, Achrol AS, McCulloch CE, Ha C, Lum K, Zaroff JG, Ko NU, Johnston SC, Sidney S, Marchuk DA, Lawton MT, Kwok PY, Young WL (2006) Apoliprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations. Neurosurgery 58: 838–843
Quick CM, Hashimoto T, Young WL (2001) Lack of flow regulation may explain the development of arteriovenous malformations. Neurol Res 23: 641–644
Risch N (1990) Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 46: 222–228
Ritvo ER, Jorde LB, Mason-Brothers A, Freeman BJ, Pingree C, Jones MB, McMahon WM, Petersen PB, Jenson WR, Mo A (1989) The UCLA-University of Utah epidemiologic survey of autism: recurrence risk estimates and genetic counseling. Am J Psychiatry 146: 1032–1036
Rogers MS, D’Amato RJ(2006) The effect of genetic diversity on angiogenesis. Exp Cell Res 312: 561–574
Sabbà C, Pasculli G, Lenato GM, Suppressa P, Lastella P, Memeo M, Dicuonzo F, Guant G (2007) Hereditary hemorragic telangiec-tasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost 5: 1149–1157
Satomi J, Mount RJ, Toporsian M, Paterson AD, Wallace MC, Harrison RV, Letarte M (2003) Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia. Stroke 34: 783–789
Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L, Löwik CW, ten Dijke P (2007) BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120: 964–972
Shaked Y, Bertolini F, Man S, Rogers MS, Cervi D, Foutz T, Rawn K, Voskas D, Dumont DJ, Ben-David Y, Lawler J, Henkin J, Huber J, Hicklin DJ, D’Amato RJ, Kerbel RS (2005) Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell 7: 101–111
Simon M, Franke D, Ludwig M, Aliashkevich AF, Köster G, Oldenburg J, Boström A, Ziegler A, Schramm J (2006) Association of a polymorphism of the ACVRL1 gene with sporadic arteriovenous malformations of the central nervous system. J Neurosurg 104: 945–949
Simon M, Schramm J, Ludwig M, Ziegler A (2007) Response to neurosurgical forum letter to the Editor “Arteriovenous Malformation” by Young et al. J Neurosurg 106: 731–733
Singh V, Smith WS, Lawton MT, Halbach VV, Young WL (2006) Thrombophilic mutation as a new high-risk feature in DAVF patients (abstract S-99). Ann Neurol 60(Suppl 3): S30
Srinivasan S, Hanes MA, Dickens T, Porteous ME, Oh SP, Hale LP, Marchuk DA (2003) A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Hum Mol Genet 12: 473–482
Stapf C, Mast H, Sciacca RR, Berenstein A, Nelson PK, Gobin YP, Pile-Spellman J, Mohr JP (2003) The New York Islands AVM Study: design, study progress, and initial results. Stroke 34: e29–e33
ten Dijke P, Arthur HM (2007) Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8: 857–869
Thomas B, Eyries M, Montagne K, Martin S, Agrapart M, Simerman-Francois R, Letarte M, Soubrier F (2007) Altered endothelial gene expression associated with hereditary haemorrhagic telangiectasia. Eur J Clin Invest 37: 580–588
Toporsian M, Gros R, Kabir MG, Vera S, Govindaraju K, Eidelman DH, Husain M, Letarte M (2005) A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 96: 684–692
Urness LD, Sorensen LK, Li DY (2000) Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26: 328–331
van Beijnum J, van der Worp HB, Schippers HM, van Nieuwenhuizen O, Kappelle LJ, Rinkel GJ, Berkelbach van der Sprenkel JW, Klijn CJ (2007) Familial occurrence of brain arteriovenous malformations: a systematic review. J Neurol Neurosurg Psychiatry 78: 1213–1217
Vikkula M, Boon LM, Carraway KL 3rd, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB, Olsen BR(1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87: 1181–1190
Wouters V, Limaye N, Uebelhoer M, Mulliken JB, Boon LM, Vikkula M (2007) Sporadic venous malformation is caused by somatic mutations in TIE2 (Abstract). American Society of Human Genetics 57th Annual Meeting, San Diego, CA
Xu B, Wu YQ, Huey M, Arthur HM, Marchuk DA, Hashimoto T, Young WL, Yang GY (2004) Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain. J Cereb Blood Flow Metab 24: 237–244
Young WL, Kader A, Ornstein E, Baker KZ, Ostapkovich N, Pile-Spellman J, Fogarty-Mack P, Stein BM (1996) Cerebral hyperemia after arteriovenous malformation resection is related to “breakthrough” complications but not to feeding artery pressure. The Columbia University Arteriovenous Malformation Study Project. Neurosurgery 38: 1085–1095
Zhu Y, Lawton MT, Du R, Shwe Y, Chen Y, Shen F, Young WL, Yang GY (2006) Expression of hypoxia-inducible factor-1 and vascular endothelial growth factor in response to venous hypertension. Neurosurgery 59: 687–696
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag
About this paper
Cite this paper
Kim, H. et al. (2008). Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations. In: Zhou, LF., et al. Cerebral Hemorrhage. Acta Neurochirurgica Supplementum, vol 105. Springer, Vienna. https://doi.org/10.1007/978-3-211-09469-3_38
Download citation
DOI: https://doi.org/10.1007/978-3-211-09469-3_38
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-09468-6
Online ISBN: 978-3-211-09469-3
eBook Packages: MedicineMedicine (R0)